Rallybio Corporation
RLYB
$16.99
$0.030.18%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 43.67M | -8.28M | -5.85M | 16.02M | -9.70M |
| Total Depreciation and Amortization | 2.00K | 3.00K | 3.00K | 35.00K | 26.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 437.00K | 562.00K | 677.00K | -21.42M | 1.75M |
| Change in Net Operating Assets | 1.82M | -265.00K | 493.00K | -1.19M | -450.00K |
| Cash from Operations | 45.92M | -7.98M | -4.68M | -6.55M | -8.38M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.50M | 17.90M | 3.93M | 29.23M | 3.04M |
| Cash from Investing | 5.50M | 17.90M | 3.93M | 29.23M | 3.04M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 131.00K | 3.00K | 6.00K | 0.00 | 10.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 131.00K | 3.00K | 6.00K | 0.00 | 10.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.55M | 9.93M | -748.00K | 22.68M | -5.33M |